BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11342446)

  • 1. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state.
    Yasunaga Ji ; Sakai T; Nosaka K; Etoh Ki ; Tamiya S; Koga S; Mita S; Uchino M; Mitsuya H; Matsuoka M
    Blood; 2001 May; 97(10):3177-83. PubMed ID: 11342446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.
    Satou Y; Utsunomiya A; Tanabe J; Nakagawa M; Nosaka K; Matsuoka M
    Retrovirology; 2012 May; 9():46. PubMed ID: 22647666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in naïve T cell production due to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development.
    Gomes JAN; da Silva Dias GA; Fujihara S; Yoshikawa GT; Koyama RVL; Sousa RCM; Quaresma JAS; Fuzii HT
    Immunobiology; 2021 Jan; 226(1):152050. PubMed ID: 33338979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
    Eiraku N; Hingorani R; Ijichi S; Machigashira K; Gregersen PK; Monteiro J; Usuku K; Yashiki S; Sonoda S; Osame M; Hall WW
    J Immunol; 1998 Dec; 161(12):6674-80. PubMed ID: 9862696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
    Saito M; Braud VM; Goon P; Hanon E; Taylor GP; Saito A; Eiraku N; Tanaka Y; Usuku K; Weber JN; Osame M; Bangham CR
    Blood; 2003 Jul; 102(2):577-84. PubMed ID: 12560226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers.
    Coutinho R; Grassi MF; Korngold AB; Olavarria VN; Galvão-Castro B; Mascarenhas RE
    BMC Infect Dis; 2014 Aug; 14():453. PubMed ID: 25148903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking.
    Sonoda J; Koriyama C; Yamamoto S; Kozako T; Li HC; Lema C; Yashiki S; Fujiyoshi T; Yoshinaga M; Nagata Y; Akiba S; Takezaki T; Yamada K; Sonoda S
    Cancer Sci; 2004 Jul; 95(7):596-601. PubMed ID: 15245597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
    Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
    Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
    Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
    J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers.
    Hashimoto K; Higuchi I; Osame M; Izumo S
    J Neurol Sci; 1998 Jul; 159(1):67-72. PubMed ID: 9700706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
    Araya N; Sato T; Yagishita N; Ando H; Utsunomiya A; Jacobson S; Yamano Y
    Viruses; 2011 Sep; 3(9):1532-48. PubMed ID: 21994794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study.
    Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
    Br J Ophthalmol; 1995 Mar; 79(3):270-6. PubMed ID: 7703209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-1-infected thymic epithelial cells convey the virus to CD4
    Carvalho Barros LR; Linhares-Lacerda L; Moreira-Ramos K; Ribeiro-Alves M; Machado Motta MC; Bou-Habib DC; Savino W
    Immunobiology; 2017 Dec; 222(12):1053-1063. PubMed ID: 28888743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
    Novaes R; Freire-de-Lima CG; de Albuquerque RC; Affonso-Mitidieri OR; Espindola O; Lima MA; de Andrada Serpa MJ; Echevarria-Lima J
    Immunobiology; 2013 Sep; 218(9):1166-74. PubMed ID: 23669236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
    Césaire R; Dehée A; Lézin A; Désiré N; Bourdonné O; Dantin F; Béra O; Smadja D; Abel S; Cabié A; Sobesky G; Nicolas JC
    AIDS Res Hum Retroviruses; 2001 Jun; 17(9):799-805. PubMed ID: 11429121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats.
    Ishiguro N; Abe M; Seto K; Sakurai H; Ikeda H; Wakisaka A; Togashi T; Tateno M; Yoshiki T
    J Exp Med; 1992 Oct; 176(4):981-9. PubMed ID: 1402668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.